BERNSTEIN HAROLD (President, R&D & CMO) sold 25.16K shares of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.01M. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/9/2026ACC: 0002050172-26-000006
Officer· President, R&D & CMO
Since Mar 2026
-25.16K
Net shares
Net seller
$1.01M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
25.16K acquired · 50.31K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+25.16K
Price / share
$10.42
Trade value
$262.13K
% of position
New position
1/7/2026
0.00→25.16K
Common Stock
Direct
Shares
−25.16K
Price / share
$40.20
Trade value
$1.01M
% of position
New position
1/7/2026
25.16K→0.00
Total
Net shares
+0.00
Net value
-$749.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/7/2026 | M · Option Exercise | +25.16K | $10.42 | $262.13K | New position | 0.00 | 25.16K |
| Common Stock Direct | 1/7/2026 | S · Sale | −25.16K | $40.20 | $1.01M | New position | 25.16K | 0.00 |
| Total | +0.00 | -$749.17K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
25.16K shares
Shares
−25.16K
Strike price
10.42
Held after
312.41K
Exercisable
—
1/7/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock25.16K shares | 1/7/2026 | M · Option Exercise | −25.16K | 10.42 | — | 312.41K |